- Home
- SGMO
SGMO
Sangamo Therapeutics Inc.
as 03-28-2025 4:00pm EST
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | RICHMOND |
| Market Cap: | N/A | IPO Year: | 2000 |
| Target Price: | $5.17 | AVG Volume (30 days): | 5.4M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.30 - $3.18 | Next Earning Date: | 03-17-2025 |
| Revenue: | $57,800,000 | Revenue Growth: | -67.20% |
| Revenue Growth (this year): | -8.08% | Revenue Growth (next year): | 41.81% |
Latest Sangamo Therapeutics Inc. News
SGMO Breaking Stock News: Dive into SGMO Ticker-Specific Updates for Smart Investing
MT Newswires
10 days ago
Truist Removes Price Target From Sangamo Therapeutics, Keeps Buy Rating; Price Target Had Been $5
Thomson Reuters StreetEvents
11 days ago
Q4 2024 Sangamo Therapeutics Inc Earnings Call
GuruFocus.com
11 days ago
Sangamo Therapeutics Inc (SGMO) Q4 2024 Earnings Call Highlights: Strategic Advances and ...
Zacks
12 days ago
Sangamo Therapeutics (SGMO) Reports Q4 Loss, Misses Revenue Estimates
Associated Press Finance
12 days ago
Sangamo: Q4 Earnings Snapshot
Business Wire
12 days ago
Sangamo Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
Business Wire
23 days ago
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2024 Earnings Call and Participation in Upcoming Investor Conference
Simply Wall St.
a month ago
Sangamo Therapeutics (NASDAQ:SGMO shareholders incur further losses as stock declines 15% this week, taking five-year losses to 89%
Compare SGMO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SGMO Sangamo Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.